Copyright
©The Author(s) 2025.
World J Cardiol. Jun 26, 2025; 17(6): 105330
Published online Jun 26, 2025. doi: 10.4330/wjc.v17.i6.105330
Published online Jun 26, 2025. doi: 10.4330/wjc.v17.i6.105330
Table 2 Multivariate regression analysis for pericardial effusion group in left ventricular assist device
Comorbidity | Odds ratio (95%CI) | P value |
Liver disease | 1.721 (1.429- 2.063) | 0.001 |
Chronic kidney disease | 1.235 (1.052- 1.452) | 0.009 |
Percutaneous coronary intervention | 2.263 (1.083 -4.232) | 0.015 |
Peripheral vascular disease | 0.579 (0.328 -0.942) | 0.034 |
Hypothyroidism | 1.269 (1.041- 1.538) | 0.016 |
Diabetes mellitus types 1&2 | 0.671 (0.563 -0.798) | 0.001 |
Congestive heart failure | 2.232 (1.249 -4.523) | 0.009 |
Electrolyte derangement | 1.290 (1.083-1.541) | 0.004 |
Afib | 1.387 (1.179-1.633) | 0.001 |
CAD | 2.890 (2.212-3.729) | 0.001 |
Dyslipidemia | 0.702 (0.590- 0.833) | 0.001 |
- Citation: Khan MZ, Brailovsky Y, Bhuiyan MAN, Marhefka G, Faisal ASM, Sircar A, O'Neill P, Rame JE, Franklin S, Waqas M, Shah H, Rajapreyar I, Alvarez RJ. Incidence, risk factors and clinical outcomes of pericardial effusion in left ventricular assist device patients. World J Cardiol 2025; 17(6): 105330
- URL: https://www.wjgnet.com/1949-8462/full/v17/i6/105330.htm
- DOI: https://dx.doi.org/10.4330/wjc.v17.i6.105330